loading

Finanzdaten der Intensity Therapeutics Inc-Aktie (INTS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
1.04%
2.733
2.705 3.394 3.203 3.57
Operating Income/Loss
1.04%
-2.733
-2.705 -3.394 -3.203 -3.57
Income/Loss From Continuing Operations Before Tax
5.28%
-2.671
-2.537 -3.347 -3.181 -3.513
Income/Loss From Continuing Operations After Tax
5.28%
-2.671
-2.537 -3.347 -3.181 -3.513
Net Income/Loss
5.28%
-2.671
-2.537 -3.347 -3.181 -3.513
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
128.12%
43.04
18.87 15.17 0.1646 13.80
Diluted Average Shares
128.12%
43.04
18.87 15.17 0.1646 13.80
Basic Earnings Per Share
53.85%
-0.06
-0.13 -0.22 -0.22 -0.25
Diluted Earnings Per Share
53.85%
-0.06
-0.13 -0.22 -0.22 -0.25
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$46.06
price up icon 0.41%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$141.15
price up icon 1.23%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):